SLDB

Solid Biosciences Stock Analysis

AI Rating

Neutral
  • Quality0/10
  • Growth↓ 3/10
  • Value↑ 5/10
Solid Biosciences sales and earnings growth
SLDB Growth
Neutral
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↑ 34.97%
  • FCF Y/Y↓ -56.32%
Solid Biosciences gross and profit margin trends
SLDB Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC 5Y↓ -89.14%
Solid Biosciences net debt vs free cash flow
SLDB Risk
Great
  • Debt / Equity↓ 0.1
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -859.7

Solid Biosciences stock volatility is in-line with the overall market. We give it a Great risk rating.

↗ More Biotechnology stocks